William Hollingworth: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "{{Coord|XX.XXXXX|YY.YYYYY|display=title}}" to "")
m (Text replacement - "pages = –" to "pages = ")
Line 37: Line 37:
| doi = 10.1136/bmjopen-2016-011255
| doi = 10.1136/bmjopen-2016-011255
| issn = 2044-6055
| issn = 2044-6055
| volume = 6      | issue = 7      | pages = –011255
| volume = 6      | issue = 7      | pages = 011255
| last1 = Brigden                | first1 = Amberly
| last1 = Brigden                | first1 = Amberly
| last2 = Beasant                | first2 = Lucy
| last2 = Beasant                | first2 = Lucy

Revision as of 11:31, March 22, 2021

William Hollingworth, B.Sc., M.Sc., Ph.D., is a UK researcher whose research includes the FINE trial, and the SMILE trial, both of which aim to help teenagers or adolescents with chronic fatigue syndrome (CFS).

Notable studies[edit | edit source]

  • 2016, Managed Activity Graded Exercise iN Teenagers and pre-Adolescents (MAGENTA) feasibility randomised controlled trial: study protocol[1]
  • 2018, Specialist Medical Intervention and Lightning Evaluation (SMILE)


Clinic location[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website
  • YouTube
  • Address: clinic/lab-address-goes-here ()

See also[edit | edit source]

Learn more[edit | edit source]

  • Wikipedia
  • Institution

References[edit | edit source]